Senate and House comprehensive health reform bills
FDA regulations affecting MRSA products; FDA Hatch-Waxman and patent issues; Comparative effectiveness research; ARRA 
Patent Reform- S515, HR 1260
Follow-on biologics- HR1427, HR 1548
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
FOLEY HOAG LLP
1717 K Street, N.W., Suite 1200, Washington, DC, 20006, US
BARRETT THORNHILL PAUL KIM SUSIE AHN (Congressman Honda Staff; Congressman Becerra, Staff)
Congressman Honda Staff; Congressman Becerra, Staff